Will intellectual property (IP) wars over patent rights to one of the most exciting new stem cell technologies hold back getting novel therapies to patients such as IPS cells? Unfortunately, it’s very possible. Induced pluripotent stem (iPS) cells are very cool stem cells made from non-stem cells through a process called cellular reprogramming. iPS cells […]
Putting the IP in iPS cells: patent war looming? Read More »
There was a time, not so long ago, when the religious right hailed the discovery of induced pluripotent stem (iPS) cells. Headlines blared from the extreme right on the Internet such as, “Embryonic stem cells obsolete”. Even the same kind of thing, saying, “The stem cell debate is dead”. You see opponents of embryonic stem
Why the extreme religious right are turning against iPS cells Read More »
One of the most common myths is that stem cells are a zero sum game. What’s a zero sum game? It’s a dynamic where the overall good in a given situation or system stays the same. What this means is that in a zero sum game, if something is good for one person, it must
The myth of stem cells as a zero sum game Read More »
One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You
Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »
If you are wondering, “How will iPS cells get to help patients?” part of the answer is perhaps the big player and Japanese Institution, Riken and its arm Retina Institute of Japan. The stem cell field is still abuzz about induced pluripotent stem (iPS) cells 7 years after their discovery. This amazing embryonic stem cell-like cells can
Meet Retina Institute of Japan: translating iPS cells Read More »
The Harvard Stem Cell Institute yesterday posted on Facebook that they will make the biggest announcement in their history tomorrow. Big hat tip to Mohammed Mostajo for the heads up and pic on this one. Thanks! What’s that all about? I’ve been working on my sources! Possible predictions…. A. SCNT-production of genetically normal human embryonic stem cells
A relatively newly recognized, important player in the stem cell field is a molecule called histone H3.3. Histones are key components of chromatin with integral roles in regulating almost all aspects of cell behavior through orchestrating functions such as transcription and chromosome segregation. Histone H3.3 knockout My lab has just (April 9) published new studies
Histone H3.3: giving cells epigenetic flexibility Read More »
Below, guest blogger, John Carbona gives us his account (including pictures) of Day 2 of the Vatican Stem Cell Meeting, which included a talk by Nobel Laureate John Gurdon. Note, you can read John’s post on Day 1 of the meeting including more great pictures here. Friday, April 12, 2012 The Second International Vatican Adult
John Carbona on Day 2 of Vatican Stem Cell Meeting including Gurdon Talk Read More »
The Vatican 2nd Stem Cell Meeting starts tomorrow and by the looks of the schedule, which was just recently posted, it should be a very interesting adult stem cell meeting. The range of speakers runs from patients to celebrity advocates such as Meredith Vieira to Nobel Laureate Dr. John Gurdon to stellar cancer researcher, Ron
Schedule is up for Vatican Stem Cell Meeting Read More »
Below are links to specific court documents and filings in stem cell-related legal proceedings. (I’ve also placed in parentheses links to my posts/analysis on these). Enjoy, especially you lawyers and investors. It’s a work in progress so expect more cases and documents to appear. In fact, if you have suggested additions please add them (plus
Your stem cell legal documents hub Read More »